TI
AUPH icon

Trexquant Investment’s Aurinia Pharmaceuticals AUPH Stock Holding History

Trexquant Investment’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-523,950
Closed -$7.76M – 1888
2026
Q1 		$7.76M Sell
523,950
-158,277
-23% -$2.31M 0.06% 469
2025
Q4 		$10.9M Sell
682,227
-118,856
-15% -$1.68M 0.1% 282
2025
Q3 		$8.85M Buy
801,083
+401,650
+101% +$4.39M 0.09% 345
2025
Q2 		$3.38M Sell
399,433
-301,205
-43% -$2.41M 0.04% 685
2025
Q1 		$5.63M Buy
700,638
+258,620
+59% +$2.1M 0.07% 453
2024
Q4 		$3.97M Sell
442,018
-141,004
-24% -$1.15M 0.05% 607
2024
Q3 		$4.27M Buy
583,022
+339,520
+139% +$2.11M 0.05% 535
2024
Q2 		$1.39M Sell
243,502
-50,699
-17% -$267K 0.02% 883
2024
Q1 		$1.47M Buy
+294,201
New +$2M 0.03% 766
2023
Q4 		– Sell
-54,403
Closed -$423K – 1416
2023
Q3 		$423K Sell
54,403
-265,615
-83% -$2.6M 0.01% 1089
2023
Q2 		$3.1M Buy
320,018
+134,576
+73% +$1.4M 0.08% 346
2023
Q1 		$2.03M Buy
185,442
+87,618
+90% +$772K 0.06% 453
2022
Q4 		$423K Sell
97,824
-5,108
-5% -$29.6K 0.01% 978
2022
Q3 		$774K Buy
102,932
+59,061
+135% +$511K 0.03% 627
2022
Q2 		$441K Buy
+43,871
New +$490K 0.02% 901
2022
Q1 		– Sell
-21,210
Closed -$485K – 1342
2021
Q4 		$485K Buy
+21,210
New +$503K 0.03% 656
2021
Q3 		– Sell
-25,960
Closed -$336K – 1123
2021
Q2 		$336K Sell
25,960
-9,688
-27% -$123K 0.03% 658
2021
Q1 		$463K Buy
+35,648
New +$517K 0.04% 542
2020
Q4 		– Sell
-19,081
Closed -$281K – 1014
2020
Q3 		$281K Buy
+19,081
New +$276K 0.02% 941
2020
Q1 		– Sell
-66,304
Closed -$1.34M – 1096
2019
Q4 		$1.34M Buy
+66,304
New +$611K 0.08% 299

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's AUPH Position: Q2 2026 in Review

Trexquant Investment sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 523,950 shares — an estimated $7.76M sold.

Trexquant Investment first reported a position in AUPH in Q4 2019 and held it in 20 quarters. The position peaked at $10.9M in Q4 2025. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Trexquant Investment reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 523,950 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $7.76M.
  • Trexquant Investment first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 20 quarters.
  • Trexquant Investment's Aurinia Pharmaceuticals position peaked at $10.9M in Q4 2025.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.